Forte Biosciences, Inc. - Common Stock (FBRX)

CUSIP: 34962G208

Q4 2025 13F Holders as of 31 Dec 2025

Security identity
Shares outstanding
6,120,451
Holder snapshot
Share change
+1,950,222
Reported price per share
$27.27
Number of holders
59
Value change
+$55,513,195
Number of buys
44
Number of sells
13

Security key

34962G208

Report period

Q4 2025

Institutions

59

Top holders

10

Ownership snapshot

Top reported holders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FEDERATED HERMES, INC.
13D/G signal
FEDERATED HERMES, INC.
Evidence rows
15
Latest as of
30 Sep 2025
13F 13D/G Lead comparable stake: 13% 13D/G row: FEDERATED HERMES, INC. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
FEDERATED HERMES, INC.
13F 13D/G
Company
13%
from 13D/G
$24,530,700
1,635,380 shares
30 Sep 2025
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13D/G 13F
Company
10%
$13,378,307
1,268,086 shares
+$6,618,184 30 Jun 2025
ORBIMED ADVISORS LLC
13F 13D/G
Company
8%
from 13D/G
$17,954,325
1,196,955 shares
30 Sep 2025
Ikarian Capital, LLC
13D/G 13F
Company
5%
$6,516,387
617,667 shares
+$89,063 30 Jun 2025
Farallon Capital Partners, L.P.
13D/G
Dapice Joshua J.
3.4%
$12,130
221,027 shares
$0 31 Dec 2024
PERCEPTIVE ADVISORS LLC
13D/G
2.5%
$1,209,840
163,935 shares
$0 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
59
Shares
11,522,905
Rows available
59
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
42
Q4 2025 holders
59
Holder diff
17
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .